Eagle Pharmaceuticals Inc (EGRX)

Finanzdaten der Eagle Pharmaceuticals Inc-Aktie (EGRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.50% 64.65	66.31	60.70	65.90
Cost Of Revenue	2.55% 16.86	17.30	18.24	20.87
Gross Profit	2.48% 47.79	49.01	42.46	45.03
Operating Expenses	0.68% 37.48	37.23	32.99	35.57
Interest Income/Expense	4.49% 1.448	1.516	1.98	1.147
Benefits Costs and Expenses	1.29% 55.35	56.07	47.40	69.56
Costs And Expenses	0.35% 54.34	54.53	51.23	56.44
Operating Income/Loss	12.48% 10.30	11.77	9.466	9.462
Nonoperating Income/Loss	34.76% -1.006	-1.542	3.838	-13.12
Income/Loss From Continuing Operations Before Tax	9.12% 9.298	10.23	13.30	-3.663
Income Tax Expense/Benefit	7.74% 4.134	4.481	5.139	3.468
Income/Loss From Continuing Operations After Tax	10.19% 5.164	5.75	8.165	-7.131
Net Income/Loss	10.19% 5.164	5.75	8.165	-7.131
Preferred Stock Dividends And Other Adjustments	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-
Basic Average Shares	0.24% 13.09	13.06	0.0277	13.17
Diluted Average Shares	0.01% 13.15	13.15	0.0142	13.17
Basic Earnings Per Share	11.36% 0.39	0.44	0.63	-0.54
Diluted Earnings Per Share	11.36% 0.39	0.44	0.62	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-